First Time Loading...

Calithera Biosciences Inc
NASDAQ:CALA

Watchlist Manager
Calithera Biosciences Inc Logo
Calithera Biosciences Inc
NASDAQ:CALA
Watchlist
Price: 0.02 USD
Updated: May 20, 2024

Calithera Biosciences Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Calithera Biosciences Inc
Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Calithera Biosciences Inc
NASDAQ:CALA
Long-Term Debt
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Debt
$63.8B
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
16%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Debt
$21.5B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Long-Term Debt
$60.1B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Debt
$361.5m
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Debt
$2.7B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
18%

See Also

What is Calithera Biosciences Inc's Long-Term Debt?
Long-Term Debt
0 USD

Based on the financial report for Dec 31, 2022, Calithera Biosciences Inc's Long-Term Debt amounts to 0 USD.